SCHEMBL7984433

SCHEMBL7984433

CCC(=O)Nc1ncn(Cc2ccccc2C)c1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 1/20 0.47
HIF1A Q16665 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
MAPK8 P45983 1/20 0.38
ALDH1A1 P00352 4/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
TSHR P16473 2/20 0.38
THRB P10828 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987938 0.87 KDM4E (0.44) LMNAL3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL7974324 0.86 TNF (0.44) SMN1; SMN2LMNAHTTL3MBTL1KMT2A
SCHEMBL7991817 0.85 KDM4E (0.51) SMN1; SMN2LMNAHTTL3MBTL1CYP11B1
SCHEMBL7991565 0.84 TSHR (0.49) SMN1; SMN2LMNAHTTL3MBTL1KMT2A
SCHEMBL7973987 0.81 FGFR1 (0.45) SMN1; SMN2LMNAHTTCYP11B1CYP11B2
SCHEMBL7988641 0.81 KMT2A (0.44) SMN1; SMN2LMNACYP11B1CYP11B2KMT2A
SCHEMBL7987961 0.80 MAPT (0.47) LMNACYP11B1CYP11B2KMT2AAURKA
SCHEMBL9714613 0.79 CYP11B1 (0.50) SMN1; SMN2LMNACYP11B1CYP11B2KMT2A
SCHEMBL7987598 0.79 RIOK2 (0.41) SMN1; SMN2L3MBTL1KMT2AMEN1MAPK8
SCHEMBL7987930 0.79 KMT2A (0.57) SMN1; SMN2LMNAHTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed